Fig. 1
From: Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
GSDME cleavage by GzmB/caspase 3 promoted pore formation to induce pyroptosis and suppress tumour growth through the enhancement of anti-tumour adaptive immunity
